Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
11 Apr 24
EFFECT
Notice of effectiveness
1 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
POS AM
Prospectus update (post-effective amendment)
26 Mar 24
8-K
Departure of Directors or Certain Officers
26 Jan 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
14 Nov 23
8-K
Departure of Directors or Certain Officers
1 Sep 23
S-8
Registration of securities for employees
10 Aug 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
10 Aug 23
8-K
Departure of Directors or Certain Officers
2 Aug 23
8-K
Regulation FD Disclosure
27 Jul 23
8-K
Other Events
24 Jul 23
8-K
Talis Biomedical Announces 1-for-15 Reverse Stock Split
5 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
9 Jun 23
8-K
Departure of Directors or Certain Officers
23 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results
11 May 23
8-K
Other Events
8 May 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
18 Apr 23
8-K
Departure of Directors or Certain Officers
11 Apr 23
10-K
2022 FY
Annual report
22 Mar 23
8-K
Talis Announces Fourth Quarter and Full Year 2022 Financial Results
22 Mar 23
8-K
Departure of Directors or Certain Officers
10 Mar 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
25 Jan 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
8-K
Talis Biomedical Reports Third Quarter 2022 Financial Results
3 Nov 22
8-K
Other Events
12 Aug 22
S-8
Registration of securities for employees
2 Aug 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
8-K
Talis Biomedical Provides Business Update and Reports Second Quarter Financial Results
2 Aug 22
8-K
Departure of Directors or Certain Officers
10 Jun 22
8-K
Departure of Directors or Certain Officers
2 Jun 22
EFFECT
Notice of effectiveness
25 May 22
424B3
Prospectus supplement
24 May 22
CORRESP
Correspondence with SEC
20 May 22
UPLOAD
Letter from SEC
16 May 22
Latest ownership filings
SC 13G/A
GREENLIGHT CAPITAL INC
14 Feb 24
4
Andrew A Lukowiak
2 Aug 23
3
Andrew A Lukowiak
2 Aug 23
4
Rebecca Markovich
18 Jul 23
4
JULIAN BAKER
13 Jun 23
4
Randal W. Scott
12 Jun 23
4
Matthew L. Posard
12 Jun 23
4
Kimberly J Popovits
12 Jun 23
4
Melissa Gilliam
12 Jun 23
4
Rustem F. Ismagilov
12 Jun 23
4
Heinrich Dreismann
12 Jun 23
4
Heinrich Dreismann
23 May 23
3
Heinrich Dreismann
23 May 23
3
Rebecca Markovich
25 Apr 23
4
John Roger Moody Jr
11 Apr 23
4
Robert J. Kelley
11 Apr 23
SC 13D/A
BAKER BROS. ADVISORS LP
10 Mar 23
3
Raymond Cheong
10 Mar 23
SC 13G/A
ArrowMark Colorado Holdings LLC
15 Feb 23
SC 13G/A
GREENLIGHT CAPITAL INC
14 Feb 23
SC 13G/A
ArrowMark Colorado Holdings LLC
12 Sep 22
4
Randal W. Scott
13 Jun 22
4
Matthew L. Posard
13 Jun 22
4
Kimberly J Popovits
13 Jun 22
4
Rustem F. Ismagilov
13 Jun 22
4
Melissa Gilliam
13 Jun 22
4
JULIAN BAKER
13 Jun 22
SC 13D/A
BAKER BROS. ADVISORS LP
13 Jun 22
4
John Roger Moody Jr
2 Jun 22
4
Robert J. Kelley
2 Jun 22
SC 13G
GREENLIGHT CAPITAL INC
14 Feb 22
SC 13G/A
ArrowMark Colorado Holdings LLC
14 Feb 22
SC 13G/A
Boxer Capital, LLC
14 Feb 22
4
Robert J. Kelley
9 Dec 21
4
Brian J Blaser
2 Dec 21
3
Brian J Blaser
2 Dec 21
4
JULIAN BAKER
19 Nov 21
4
John Roger Moody Jr
5 Oct 21
4
Douglas Liu
5 Oct 21
4
Robert J. Kelley
5 Oct 21